Circio Holding ASA
Clinical-stage company developing circular RNA medicines and immunotherapies.
CRNA | OL
Overview
Corporate Details
- ISIN(s):
- NO0012858564 (+5 more)
- LEI:
- 5967007LIEEXZXFYNS31
- Country:
- Norway
- Address:
- Vollsveien 19, 1366 Lysaker
- Website:
- https://www.targovax.com/en/
Description
Circio Holding ASA is a clinical-stage company developing novel medicines based on circular RNA (circRNA) and immunotherapy. The company's core focus is its proprietary circVec platform, a circular RNA expression system designed to enhance the efficacy and durability of gene and cell therapies. Circio's development pipeline is directed towards immuno-oncology, targeting difficult-to-treat solid tumors, and the application of its circRNA technology to address genetic diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-27 15:35 |
Circio Holding ASA - Updated information to the notice of annual general meetin…
|
English | PDF • 120.7 KB | ||
| 2025-05-27 15:35 |
Circio Holding ASA - Updated information to the notice of annual general meetin…
|
English | HTML • 4.2 KB | ||
| 2025-05-22 05:00 |
Circio invites to R&D and corporate update webcast on 28 May 2025
|
English | HTML • 2.2 KB | ||
| 2025-05-15 13:30 |
Circio Holding ASA - Notice of annual general meeting 2025
|
Norwegian | PDF • 1.6 MB | ||
| 2025-05-15 13:30 |
Circio Holding ASA - Notice of annual general meeting 2025
|
English | HTML • 2.7 KB | ||
| 2025-05-15 10:19 |
Circio Holding ASA: Registration of share capital increase following conversion…
|
English | HTML • 2.7 KB | ||
| 2025-05-15 06:07 |
Atlas Holdings for CIRCIO
|
English | HTML • 760 bytes | ||
| 2025-05-14 06:11 |
Atlas Holdings for CIRCIO
|
English | HTML • 732 bytes | ||
| 2025-05-13 23:00 |
Circular RNA innovator Circio presents strengthened circVec gene therapy data a…
|
English | PDF • 1.9 MB | ||
| 2025-05-13 23:00 |
Circular RNA innovator Circio presents strengthened circVec gene therapy data a…
|
English | HTML • 6.1 KB | ||
| 2025-05-13 14:52 |
Circio Holding ASA - Funding requested under financing commitment from Atlas
|
English | HTML • 2.8 KB | ||
| 2025-05-13 11:07 |
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | HTML • 3.0 KB | ||
| 2025-05-07 09:28 |
Circio Holding ASA: Registration of share capital increase following conversion…
|
English | HTML • 2.7 KB | ||
| 2025-05-06 05:00 |
Circular RNA innovator Circio to present strengthened circVec gene therapy data…
|
English | HTML • 2.0 KB | ||
| 2025-05-05 09:52 |
Circio Holding ASA: Requested Conversion of Convertible Bonds
|
English | HTML • 3.4 KB |
Automate Your Workflow. Get a real-time feed of all Circio Holding ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Circio Holding ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Circio Holding ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
